Loading…

Viral Double-stranded RNAs from Vaccinia Virus Early or Intermediate Gene Transcripts Possess PKR Activating Function, Resulting in NF-κB Activation, When the K1 Protein Is Absent or Mutated

PKR is a potent antiviral molecule that can terminate infection by inhibiting protein synthesis and stimulating NF-κB activation and apoptosis. Originally, it was thought that only intermediate and late gene transcription produced double-stranded (ds) RNA to activate PKR during vaccinia virus (VACV)...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 2011-03, Vol.286 (10), p.7765-7778
Main Authors: Willis, Kristen L., Langland, Jeffrey O., Shisler, Joanna L.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c443t-94d2db202294c2c3acf66c419c9391cb7c904fa3f815d4a800638247843527aa3
cites cdi_FETCH-LOGICAL-c443t-94d2db202294c2c3acf66c419c9391cb7c904fa3f815d4a800638247843527aa3
container_end_page 7778
container_issue 10
container_start_page 7765
container_title The Journal of biological chemistry
container_volume 286
creator Willis, Kristen L.
Langland, Jeffrey O.
Shisler, Joanna L.
description PKR is a potent antiviral molecule that can terminate infection by inhibiting protein synthesis and stimulating NF-κB activation and apoptosis. Originally, it was thought that only intermediate and late gene transcription produced double-stranded (ds) RNA to activate PKR during vaccinia virus (VACV) infection. The VACV E3 or K3 proteins squelch this effect by binding to either dsRNA or PKR. However, in the absence of the K1 protein, VACV infection activates PKR at very early times post-infection and despite the presence of E3 and K3. These data suggest that VACV infection induces PKR activation by a currently unknown mechanism. To determine this mechanism, cells were infected with K1L-containing or -deficient VACVs. By using conditions that limited the progression of the poxvirus replication cycle, we observed that early gene transcripts activated PKR in RK13 cells, identifying a new PKR-activating mechanism of poxvirus infection. Using a similar approach for HeLa cells, intermediate gene transcription was sufficient to activate PKR. RNA isolated from infected RK13 or HeLa cells maintained PKR-activating properties only when dsRNA was present. Moreover, viral dsRNA was directly detected in infected cells either by RT-PCR or immunofluorescent microscopy. Interestingly, dsRNA levels were higher in infected cells in which the K1 protein was nonfunctional. Only K1 proteins with PKR inhibitory function prevented downstream NF-κB activation. These results reveal a new PKR activation pathway during VACV infection, in which the K1 protein reduces dsRNA levels early in VACV infection to directly inhibit PKR and several of its downstream antiviral effects, thereby enhancing virus survival.
doi_str_mv 10.1074/jbc.M110.194704
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3048664</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820539227</els_id><sourcerecordid>904475276</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-94d2db202294c2c3acf66c419c9391cb7c904fa3f815d4a800638247843527aa3</originalsourceid><addsrcrecordid>eNp1kU1vEzEQhlcIREPhzBHfuLCtv7JrX5DS0pSoH1ShLdwsr3c2cbWxg-2N1L_WS_8BvwmHVJU44MtoPM_Ma89bFO8JPiC45od3jTm4INtM8hrzF8WIYMFKNiY_XxYjjCkpJR2LveJNjHc4Hy7J62KPEiJYVYtR8Xhrg-7RFz80PZQxBe1aaNH8chJRF_wK3WpjrLMaZXCI6ESH_h75gGYuQVhBa3UCdAoO0HXujSbYdYroyscIMcezOZqYZDc6WbdA08HlxLtPaA5x6P_eWYcup-Xvh6NncFv_sQSH0hLQGUFXwSfI2CyiSRPBpa3-xZCycvu2eNXpPsK7p7hf3ExPro-_luffTmfHk_PScM5SKXlL24ZiSiU31DBtuqoynEgjmSSmqY3EvNOsE2Tcci0wrpigvBacjWmtNdsvPu_mrocm_9rkV-S9qXWwKx3ulddW_VtxdqkWfqMY5qKqeB7w8WlA8L8GiEmtbDTQ99qBH6LK-rzOWlUmD3ekCXmLAbpnFYLV1nWVXVdb19XO9dzxYdfRaa_0Itiobr5TTBjOgKiEzITcEZB3tLEQVDQWnMn-BTBJtd7-d_of_fe-NA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>904475276</pqid></control><display><type>article</type><title>Viral Double-stranded RNAs from Vaccinia Virus Early or Intermediate Gene Transcripts Possess PKR Activating Function, Resulting in NF-κB Activation, When the K1 Protein Is Absent or Mutated</title><source>Open Access: PubMed Central</source><source>ScienceDirect Journals</source><creator>Willis, Kristen L. ; Langland, Jeffrey O. ; Shisler, Joanna L.</creator><creatorcontrib>Willis, Kristen L. ; Langland, Jeffrey O. ; Shisler, Joanna L.</creatorcontrib><description>PKR is a potent antiviral molecule that can terminate infection by inhibiting protein synthesis and stimulating NF-κB activation and apoptosis. Originally, it was thought that only intermediate and late gene transcription produced double-stranded (ds) RNA to activate PKR during vaccinia virus (VACV) infection. The VACV E3 or K3 proteins squelch this effect by binding to either dsRNA or PKR. However, in the absence of the K1 protein, VACV infection activates PKR at very early times post-infection and despite the presence of E3 and K3. These data suggest that VACV infection induces PKR activation by a currently unknown mechanism. To determine this mechanism, cells were infected with K1L-containing or -deficient VACVs. By using conditions that limited the progression of the poxvirus replication cycle, we observed that early gene transcripts activated PKR in RK13 cells, identifying a new PKR-activating mechanism of poxvirus infection. Using a similar approach for HeLa cells, intermediate gene transcription was sufficient to activate PKR. RNA isolated from infected RK13 or HeLa cells maintained PKR-activating properties only when dsRNA was present. Moreover, viral dsRNA was directly detected in infected cells either by RT-PCR or immunofluorescent microscopy. Interestingly, dsRNA levels were higher in infected cells in which the K1 protein was nonfunctional. Only K1 proteins with PKR inhibitory function prevented downstream NF-κB activation. These results reveal a new PKR activation pathway during VACV infection, in which the K1 protein reduces dsRNA levels early in VACV infection to directly inhibit PKR and several of its downstream antiviral effects, thereby enhancing virus survival.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M110.194704</identifier><identifier>PMID: 21183678</identifier><language>eng</language><publisher>9650 Rockville Pike, Bethesda, MD 20814, U.S.A: Elsevier Inc</publisher><subject>Apoptosis ; Data processing ; double prime K1 protein ; Double-stranded RNA ; Infection ; Microbiology ; Microscopy ; NF- Kappa B protein ; NF-kappa B ; Polymerase chain reaction ; Pox Viruses ; Poxvirus ; Protein biosynthesis ; Protein Kinase RNA (PKR) ; Replication ; Survival ; Transcription ; Vaccinia virus ; Viral Transcription ; Virus</subject><ispartof>The Journal of biological chemistry, 2011-03, Vol.286 (10), p.7765-7778</ispartof><rights>2011 © 2011 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>2011 by The American Society for Biochemistry and Molecular Biology, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-94d2db202294c2c3acf66c419c9391cb7c904fa3f815d4a800638247843527aa3</citedby><cites>FETCH-LOGICAL-c443t-94d2db202294c2c3acf66c419c9391cb7c904fa3f815d4a800638247843527aa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048664/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021925820539227$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids></links><search><creatorcontrib>Willis, Kristen L.</creatorcontrib><creatorcontrib>Langland, Jeffrey O.</creatorcontrib><creatorcontrib>Shisler, Joanna L.</creatorcontrib><title>Viral Double-stranded RNAs from Vaccinia Virus Early or Intermediate Gene Transcripts Possess PKR Activating Function, Resulting in NF-κB Activation, When the K1 Protein Is Absent or Mutated</title><title>The Journal of biological chemistry</title><description>PKR is a potent antiviral molecule that can terminate infection by inhibiting protein synthesis and stimulating NF-κB activation and apoptosis. Originally, it was thought that only intermediate and late gene transcription produced double-stranded (ds) RNA to activate PKR during vaccinia virus (VACV) infection. The VACV E3 or K3 proteins squelch this effect by binding to either dsRNA or PKR. However, in the absence of the K1 protein, VACV infection activates PKR at very early times post-infection and despite the presence of E3 and K3. These data suggest that VACV infection induces PKR activation by a currently unknown mechanism. To determine this mechanism, cells were infected with K1L-containing or -deficient VACVs. By using conditions that limited the progression of the poxvirus replication cycle, we observed that early gene transcripts activated PKR in RK13 cells, identifying a new PKR-activating mechanism of poxvirus infection. Using a similar approach for HeLa cells, intermediate gene transcription was sufficient to activate PKR. RNA isolated from infected RK13 or HeLa cells maintained PKR-activating properties only when dsRNA was present. Moreover, viral dsRNA was directly detected in infected cells either by RT-PCR or immunofluorescent microscopy. Interestingly, dsRNA levels were higher in infected cells in which the K1 protein was nonfunctional. Only K1 proteins with PKR inhibitory function prevented downstream NF-κB activation. These results reveal a new PKR activation pathway during VACV infection, in which the K1 protein reduces dsRNA levels early in VACV infection to directly inhibit PKR and several of its downstream antiviral effects, thereby enhancing virus survival.</description><subject>Apoptosis</subject><subject>Data processing</subject><subject>double prime K1 protein</subject><subject>Double-stranded RNA</subject><subject>Infection</subject><subject>Microbiology</subject><subject>Microscopy</subject><subject>NF- Kappa B protein</subject><subject>NF-kappa B</subject><subject>Polymerase chain reaction</subject><subject>Pox Viruses</subject><subject>Poxvirus</subject><subject>Protein biosynthesis</subject><subject>Protein Kinase RNA (PKR)</subject><subject>Replication</subject><subject>Survival</subject><subject>Transcription</subject><subject>Vaccinia virus</subject><subject>Viral Transcription</subject><subject>Virus</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp1kU1vEzEQhlcIREPhzBHfuLCtv7JrX5DS0pSoH1ShLdwsr3c2cbWxg-2N1L_WS_8BvwmHVJU44MtoPM_Ma89bFO8JPiC45od3jTm4INtM8hrzF8WIYMFKNiY_XxYjjCkpJR2LveJNjHc4Hy7J62KPEiJYVYtR8Xhrg-7RFz80PZQxBe1aaNH8chJRF_wK3WpjrLMaZXCI6ESH_h75gGYuQVhBa3UCdAoO0HXujSbYdYroyscIMcezOZqYZDc6WbdA08HlxLtPaA5x6P_eWYcup-Xvh6NncFv_sQSH0hLQGUFXwSfI2CyiSRPBpa3-xZCycvu2eNXpPsK7p7hf3ExPro-_luffTmfHk_PScM5SKXlL24ZiSiU31DBtuqoynEgjmSSmqY3EvNOsE2Tcci0wrpigvBacjWmtNdsvPu_mrocm_9rkV-S9qXWwKx3ulddW_VtxdqkWfqMY5qKqeB7w8WlA8L8GiEmtbDTQ99qBH6LK-rzOWlUmD3ekCXmLAbpnFYLV1nWVXVdb19XO9dzxYdfRaa_0Itiobr5TTBjOgKiEzITcEZB3tLEQVDQWnMn-BTBJtd7-d_of_fe-NA</recordid><startdate>20110311</startdate><enddate>20110311</enddate><creator>Willis, Kristen L.</creator><creator>Langland, Jeffrey O.</creator><creator>Shisler, Joanna L.</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>FBQ</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20110311</creationdate><title>Viral Double-stranded RNAs from Vaccinia Virus Early or Intermediate Gene Transcripts Possess PKR Activating Function, Resulting in NF-κB Activation, When the K1 Protein Is Absent or Mutated</title><author>Willis, Kristen L. ; Langland, Jeffrey O. ; Shisler, Joanna L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-94d2db202294c2c3acf66c419c9391cb7c904fa3f815d4a800638247843527aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Apoptosis</topic><topic>Data processing</topic><topic>double prime K1 protein</topic><topic>Double-stranded RNA</topic><topic>Infection</topic><topic>Microbiology</topic><topic>Microscopy</topic><topic>NF- Kappa B protein</topic><topic>NF-kappa B</topic><topic>Polymerase chain reaction</topic><topic>Pox Viruses</topic><topic>Poxvirus</topic><topic>Protein biosynthesis</topic><topic>Protein Kinase RNA (PKR)</topic><topic>Replication</topic><topic>Survival</topic><topic>Transcription</topic><topic>Vaccinia virus</topic><topic>Viral Transcription</topic><topic>Virus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Willis, Kristen L.</creatorcontrib><creatorcontrib>Langland, Jeffrey O.</creatorcontrib><creatorcontrib>Shisler, Joanna L.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>AGRIS</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Willis, Kristen L.</au><au>Langland, Jeffrey O.</au><au>Shisler, Joanna L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Viral Double-stranded RNAs from Vaccinia Virus Early or Intermediate Gene Transcripts Possess PKR Activating Function, Resulting in NF-κB Activation, When the K1 Protein Is Absent or Mutated</atitle><jtitle>The Journal of biological chemistry</jtitle><date>2011-03-11</date><risdate>2011</risdate><volume>286</volume><issue>10</issue><spage>7765</spage><epage>7778</epage><pages>7765-7778</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>PKR is a potent antiviral molecule that can terminate infection by inhibiting protein synthesis and stimulating NF-κB activation and apoptosis. Originally, it was thought that only intermediate and late gene transcription produced double-stranded (ds) RNA to activate PKR during vaccinia virus (VACV) infection. The VACV E3 or K3 proteins squelch this effect by binding to either dsRNA or PKR. However, in the absence of the K1 protein, VACV infection activates PKR at very early times post-infection and despite the presence of E3 and K3. These data suggest that VACV infection induces PKR activation by a currently unknown mechanism. To determine this mechanism, cells were infected with K1L-containing or -deficient VACVs. By using conditions that limited the progression of the poxvirus replication cycle, we observed that early gene transcripts activated PKR in RK13 cells, identifying a new PKR-activating mechanism of poxvirus infection. Using a similar approach for HeLa cells, intermediate gene transcription was sufficient to activate PKR. RNA isolated from infected RK13 or HeLa cells maintained PKR-activating properties only when dsRNA was present. Moreover, viral dsRNA was directly detected in infected cells either by RT-PCR or immunofluorescent microscopy. Interestingly, dsRNA levels were higher in infected cells in which the K1 protein was nonfunctional. Only K1 proteins with PKR inhibitory function prevented downstream NF-κB activation. These results reveal a new PKR activation pathway during VACV infection, in which the K1 protein reduces dsRNA levels early in VACV infection to directly inhibit PKR and several of its downstream antiviral effects, thereby enhancing virus survival.</abstract><cop>9650 Rockville Pike, Bethesda, MD 20814, U.S.A</cop><pub>Elsevier Inc</pub><pmid>21183678</pmid><doi>10.1074/jbc.M110.194704</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2011-03, Vol.286 (10), p.7765-7778
issn 0021-9258
1083-351X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3048664
source Open Access: PubMed Central; ScienceDirect Journals
subjects Apoptosis
Data processing
double prime K1 protein
Double-stranded RNA
Infection
Microbiology
Microscopy
NF- Kappa B protein
NF-kappa B
Polymerase chain reaction
Pox Viruses
Poxvirus
Protein biosynthesis
Protein Kinase RNA (PKR)
Replication
Survival
Transcription
Vaccinia virus
Viral Transcription
Virus
title Viral Double-stranded RNAs from Vaccinia Virus Early or Intermediate Gene Transcripts Possess PKR Activating Function, Resulting in NF-κB Activation, When the K1 Protein Is Absent or Mutated
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T13%3A42%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Viral%20Double-stranded%20RNAs%20from%20Vaccinia%20Virus%20Early%20or%20Intermediate%20Gene%20Transcripts%20Possess%20PKR%20Activating%20Function,%20Resulting%20in%20NF-%CE%BAB%20Activation,%20When%20the%20K1%20Protein%20Is%20Absent%20or%20Mutated&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Willis,%20Kristen%20L.&rft.date=2011-03-11&rft.volume=286&rft.issue=10&rft.spage=7765&rft.epage=7778&rft.pages=7765-7778&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M110.194704&rft_dat=%3Cproquest_pubme%3E904475276%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c443t-94d2db202294c2c3acf66c419c9391cb7c904fa3f815d4a800638247843527aa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=904475276&rft_id=info:pmid/21183678&rfr_iscdi=true